ThermoGenesis Holdings, Inc.: Nasdaq/NYSE listing notice — ThermoGenesis receives Nasdaq notice for minimum stockholders' equity deficiency

ThermoGenesis Holdings, Inc.

Nasdaq notified ThermoGenesis of non-compliance with Listing Rule 5550(b)(1) requiring at least $2.5M in stockholders' equity.
Company also fails alternative compliance measures (market value of listed securities or net income from continuing operations).
ThermoGenesis has 45 days to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
No immediate impact on listing; company is evaluating options to address deficiency.
If plan is rejected, stock faces delisting subject to appeal process.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ThermoGenesis Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

April 19, 2024, ThermoGenesis Holdings, Inc. (the “Company”) received a notice (the “Nasdaq Notice”) from The Nasdaq Stock Market (“Nasdaq”) that the Company does not presently comply with Nasdaq’s Listing Rule 5550(b)(1) that requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. Additionally, as of the date of this report, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations under Nasdaq Listing Rules. The Nasdaq Notice does not have any immediate effect on the listing of the

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001437749-24-012994

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.